Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors
Clinical trial NCT06764368 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06764368
- Sponsor
- Beijing Chest Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2027-12-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.